Surmodics Stock (NASDAQ: SRDX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 59.532K |
Day Range | - - - |
52 Wk Range | 16.790 - 39.410 |
Market Cap | $377.539M |
P/E Ratio | 67.923 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 3.95% |
Days to Cover | 11.46 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Surmodics (NASDAQ: SRDX) through any online brokerage.
Other companies in Surmodics’s space includes: NeuroPace (NASDAQ:NPCE), Axogen (NASDAQ:AXGN), SI-BONE (NASDAQ:SIBN), Semler Scientific (NASDAQ:SMLR) and Sight Sciences (NASDAQ:SGHT).
The latest price target for Surmodics (NASDAQ: SRDX) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 47.00 expecting SRDX to rise to within 12 months (a possible 77.22% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Surmodics (NASDAQ: SRDX) is $26.52 last updated April 17, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Surmodics.
Surmodics’s Q2 earnings are confirmed for Monday, April 29, 2024.
There is no upcoming split for Surmodics.
Surmodics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.